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ABSTRACT 
The aqueous extract of the senescent leaves of Artocarpus heterophyllus is traditionally used in Sri Lanka as a 
hypoglyceamic agent. It has been previously reported that the hypoglyceamic activity lies in the ethyl acetate 
fraction of the water extract (EA/W). The EA/W fraction was fractionated by chromatography on sephadex 
LH-20. Five fractions eluting with the following solvent systems were obtained. Fraction 1, 
dichloromethane/ hexane (4:1), Fraction 2, dichloromethane/acetone (3:2), Fraction 3, dichloromethane/ 
acetone (1:4), Fraction 4, dichloromethane/ methanol (1:1) and Fraction 5, methanol. These fractions were 
screened for in vivo hypoglyceamic activity. Each fraction was tested for its effect on the blood glucose levels 
of fasted normal and diabetic rats. None of the fractions caused hypoglyceamia on normal rats. However 
there was significant (p < 0.001) reduction in the blood glucose level during the first three hours after giving 
the fractions 3, 4 and 5 to diabetic rats. Among the three fractions fraction 4 showed the highest 
hypoglyceamic activity. Fractions 3, 4 and 5 were also the most active in the glucose tolerance test carried 
out on both normal and diabetic rats. However fraction 3 showed the highest activity in this assay. In both 
assays using diabetic rats fractions 3, 4 and 5 at 50 mg/kg body weight showed activity of the same order as 
glibenclamide at 5 mg/ kg body weight. These results maybe of potential use for the development of an anti 
diabetic drug from leaves of Artocarpus heterophyllus. 
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INTRODUCTION
 Diabetes mellitus is a syndrome of chronic 
hyperglyceamia due to relative insulin deficiency, 
resistance, or both[1]. During the last twenty years the 
prevalence of the disease has increased all over the world 
and it now affects all populations. The International 
Diabetes Federation (IDF) estimated that in 2013 
worldwide 387 million people were suffering from 
diabetes mellitus with projections that the number will 
increase to 592 million by 2035 [2]. The prevalence of 
diabetes and its adverse health effects has risen more 
rapidly in South Asia than in any other large region of the 
world [3]. In 2011, 8.3% of the adult population or 71.4 
million South Asians were estimated to have diabetes. In 
2013 Sri Lanka diabetes prevalence has reported 8.0% 
which means that 1.1 million people are suffering from 
diabetes mellitus [3]. Long-term complications of diabetes 
include retinopathy with potential loss of vision, 
nephropathy leading to renal failure, peripheral 
neuropathy with risk of foot ulcers leading to amputations 
and charcot joints, and autonomic neuropathy causing 
gastrointestinal, genitourinary, and cardiovascular 
symptoms and sexual dysfunction[4]. Further, diabetic 
patients have an increased rate of atherosclerotic, 
cardiovascular, peripheral arterial and cerebrovascular 
disease, hypertension and abnormalities of lipoprotein 
metabolism[4]. Mortality and morbidity are increased due 
to these complications. Currently insulin and various oral 
antidiabetic agents are used as monotherapy or in 
combination to achieve better glyceamic regulation. Many 
of these oral antidiabetic agents have a number of serious 
adverse effects and most of drugs show development of 
resistance[5]. It is still a challenge to manage diabetes 
mellitus without any side effects. The search for new drugs 
which are safer and more effective is an active area of 
research. Artocarpus heterophyllus is a well-known plant 
which belongs to family Moraceae and its leaves are used 
ethnomedically in Sri Lanka for the control of diabetes 
mellitus. The antidiabetic and hypoglyceamic effects of the 
leaf extract have been demonstrated in animal models and 
in human subjects[6-10]. A study on a rat model shows that 
the hypoglyceamic activity of the ethyl acetate fraction of 
the water extract of the leaves at a dose of 50 mg / kg body 
weight was greater than that of tolbutamide, a sulphonyl 
urea drug commonly used for treatment of hyperglyceamia 
at a dose of 15 mg / kg body weight [7,11]. In this paper we 
report our work on evaluating the potential of A. 
heterophyllus leaves for the treatment of diabetes mellitus 
through its in vivo hypoglyceamic activity of the fractions 
of ethyl acetate fraction of the water extract. 
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MATERIALS AND METHODS  
Plant materials 
 Senescent leaves of A. heterophyllus were collected 
from a plant (cultivar Waraka) growing in a home garden 
in Wijerama in the Colombo district. The Material was 
authenticated by Mr. Isuru Kariyawasam of the 
Department of Botany, University of Sri Jayewardenepura 
and a voucher specimen (B7/006(SJP)) has been deposited 
in the herbarium, Department of Botany, University of Sri 
Jayewardenepura. These leaves were washed and dried on 
air for 3 hours and crushed using a mechanical blender 
and used for extractions. 
Extraction  
Ethyl acetate soluble fraction of the water extract of A. 
heterophyllus leaves (EA/W) 
 A sample of senescent leaves of A. heterophyllus 
(500 g) was extracted by refluxing with 2500 mL of 
distilled water in a 5 L round bottom flask for 4 hours. The 
extract was filtered through a cotton wool plug fixed to a 
funnel while hot and allowed to cool to room temperature. 
The extract was concentrated under vacuum until the total 
volume was 5 mL. Excess ethanol was added to precipitate 
the high molecular weight fraction. The mixture was 
filtered and the filtrate was concentrated under vacuum 
until the total volume was 500 mL and extracted with ethyl 
acetate (300 mL x 6) in a separatory funnel. The ethyl 
acetate extracts were combined and the solvent was 
evaporated under reduced pressure to obtain a brownish-
black sticky solid (1.2 g) (EA/W). 
Fractionation of EA/W 
 Sephadex LH-20 was soaked in hexane: 
dichloromethane (1:4) overnight and packed it into a 
column (30 g, 1.6 cm x 30 cm). Sticky solid EA/W (1.2 mg) 
was soaked to 1 g of Sephadex LH-20 and placed on the top 
of the column. Column was eluted with 5 different solvents 
and fractions were collected separately. Fraction 1 was 
eluted with dichloromethane/hexane 4:1 (1 L) and 
fraction 2, 3, 4 and 5 were eluted with dichloromethane/ 
acetone 3:2 (1 L), dichloromethane/acetone 1:4 (0.9 L), 
dichloromethane/ methanol 1:1 (1 L) and methanol (1 L) 
respectively. The weights of each fraction after 
evaporation of the solvent were obtained and distribution 
of compounds were analyzed by TLC (Silica (GF 254) with 
solvent systems; ethyl acetate: dichloromethane: 
methanol: formic acid (58:38:2:2) and ethyl acetate: formic 
acid: glacial acetic acid: water (100:11:11:27). 
Animal model 
 Male Wistar rats approximately 8 - 12 weeks old, 
weighing 150 - 300 g from Animal Centre, HEJ Research 
Institute, Karachi, Pakistan were used for the study. The 
animals were housed in standard cages, three per cage 
with autoclaved sawdust as bedding material. They were 
fed pelleted standard rat feed and water ad libitum. Rats 
were maintained at 12 hours light/dark cycle at room 
temperature. They were individually identified by colour 
markings on their body. The rats were handled in 
accordance with the standard guide for the care and use of 
laboratory animals and necessary skills for rat handling 
were obtained before commencing the research. 
For in vivo studies on normoglyceamic rats 42 rats were 
divided into 7 groups (groups A -G) and for in vivo studies 
in the diabetic model experiment 48 rats were divided into 
8 groups (groups H - O). The animals used were kept 
fasted overnight before commencement of experiment. 
 Induction of diabetes mellitus  
 Rats in groups H – O were fasted overnight and 
nicotinamide was given intraperitonially (120 mg/ kg 
body weight). Then after 15 minutes streptozotocin was 
given intravenous (60 mg/kg body weight). Normal food 
and 5% glucose (instead of water) was given for 24 hours 
ad libitum. After that until two weeks normal food and 
water was given ad libitum. The rats were fasted overnight 
and their fasting blood glucose levels were measured to 
check whether diabetes has been induced ( > 120 mg/ dL).  
Effect on blood glucose levels in normoglyceamic rats 
 Animals in groups A – G were fasted overnight and 
fasting blood glucose levels of the rats were measured. 
After that group A served as control and received water. 
Group B received a single dose of 50 mg/ kg body weight 
EA/W. Groups C, D, E, F and G received a single dose of 
fraction 1,2,3,4 and 5 (50 mg/ kg body weight) 
respectively which were obtained from sephadex LH-20 
column. All samples were given orally. After that blood 
glucose levels were measured at 1 hour, 2 hours and 3 
hours after administration of sample. Blood was obtained 
from the tail vein. Blood glucose was measured using a 
glucometer (Accu-Check glucometer) 
Effect on fasting blood glucose levels in diabetic rats 
 Diabetic rats of groups H – O were fasted 
overnight and fasting blood glucose levels of the rats were 
measured. Group H served as control and received water. 
Group I received a single dose of 50 mg/ kg body weight 
EA/W. Groups J, K, L, M and N received fraction 1,2,3,4 and 
5 (50 mg/ kg body weight) respectively which were 
obtained from Sephadex LH-20 column respectively. 
Group O received glibenclamide at 5 mg/ kg body weight. 
All samples were given orally. After that blood glucose 
levels were measured at 1 hour, 2 hours and 3 hours after 
administration of sample. Blood was obtained from the tail 
vein. Blood glucose was immediately measured using a 
glucometer (Accu-Check glucometer). 
Effect on glucose tolerance in normoglyceamic rats 
 After 2 weeks of the experiment using 
normoglyceamic rats, animals in groups A – G were kept 
fasted overnight and fasting blood glucose levels of the 
rats were measured. After that group A served as control 
and received water. Group B received a single dose of 50 
mg/kg body weight EA/W. Groups C, D, E, F and G received 
a single dose of fraction (50 mg/kg body weight)1,2,3,4 
and 5 respectively which were obtained from Sephadex 
LH-20 column. All samples were given orally. After 1hour 
blood glucose level was measured and a glucose load (3 
g/kg body weight) was administrated. After that blood 
glucose levels were measured at 1 hour, 2 hours, and 3 
hours after the administration of glucose load. Blood was 
obtained from the tail vein. Blood glucose was immediately 
measured using a glucometer (Accu-Check glucometer). 
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Effect on glucose tolerance in diabetic rats 
 After 2 weeks of the experiment diabetic rats, 
animals in groups H – O were kept fasted overnight and 
fasting blood glucose levels of the rats were measured. 
Group H served as control and received water. Group I 
received a single dose of 50 mg/ kg body weight EA. 
Groups J, K, L, M and N received a single dose (50 mg/kg 
body weight) of fraction 1,2,3,4 and 5 respectively which 
were obtained from Sephadex LH-20 column. All samples 
were given orally. After 1hour blood glucose level was 
measured and a glucose load (3 g/kg body weight) was 
administrated. Blood glucose level was measured at 1 
hour, 2 hours and 3 hours after the administration of 
glucose load. Blood was obtained from the tail vein. Blood 
glucose was immediately measured using a glucometer 
(Accu-Check glucometer). 
RESULTS AND DISCUSSION  
 The fractions (1 -5) obtained from the Sephadex 
LH- 20 column were tested for their hypoglyceamic 
activity to identify active fractions. The effect of the 
fractions on the glucose levels in fasted rats, with and 
without the administration of a glucose load was tested. 
Both normal and streptozotocin induced diabetic rats were 
subjected to these tests. 
 Treatment of the rats with nicotinamide and 
streptozotocin resulted in elevated plasma glucose levels 
consistent with diabetes (>120 mg/ dL), whereas non-
treated rats without nicotinamide and streptozotocin had 
normal glucose levels (< 120 mg/ dL). 
Effects on blood glucose levels in normoglyceamic rats 
after administration of fractions of EA/W 
 According to the results obtained neither EA/W 
nor the fractions brought about any significant lowering or 
increasing of the blood glucose levels. This indicates that 
these samples do not lead to hypoglyceamic activity in the 
normal rat. This is an advantage in antidiabetic drug as it 
reduces the risk of hypoglyceamia.  
Effect on blood glucose levels in diabetic rats after 
administration of fractions of EA/W 
 Figure 1 describes the variation of blood glucose 
levels with time after administration of fractions of EA/W 
and the Figure 2 shows the reduction in blood glucose 
level with time for the different fractions. 
 It can be seen that there was no significant change 
in the blood glucose level of the control group during the 
three hours. Surprisingly in fraction 1 there was an 
increase in the blood glucose level in the 1st hour which 
then came back to the starting level after the second hour 
and lowered at the 3rd hour. Fraction 2 did not show any 
significant change (p > 0.1) in the first and second hour 
after administration of fractions of EA/W. But at the 3rd 
hour it showed significant reduction (p < 0.01) with 
respect to control group. Figure 2 clearly show that the 
highest reduction occurs at second hour after 
administration of the samples. Also it shows fraction 3, 4 
and 5 have significant reduction (p < .001) with respect to 
control group. Fraction 4 showed the highest reduction at 
the second hour after administration of sample. When 
comparing with EA/W fraction 3, 4 and 5 have significant 
enhancement (p < 0.01) in hypoglyceamic activity over 
parent EA/W at first and second hours. Fraction 4 shows 
significant reduction even at the third hour (p < 0.01) over 
the parent EA/W. When comparing with glebenclamide, 
fractions 3, 4 and 5 show a significant reduction in blood 
glucose level (p < 0.01) at second hour of administration of 
fractions. It should be noted that the dosage of 
glibenclamide was one tenth of the dose of the fractions.  
Effects on blood glucose levels in normoglyceamic rats 
with the administration of a glucose load (Glucose 
tolerance Test)  
 Figure 3 shows the variation of blood glucose 
levels with time and Figure 4 shows the change in blood 
glucose level with respect to the control (Percentage 
reduction in blood glucose level with respect to normal 
control). The more sensitive time for evaluating the effects 
of the fractions will be when the blood glucose level is at 
its highest. In all groups the highest increase in blood 
glucose level is observed at 1st hour after glucose load, 
after which it reduces over a period of 2 hours and almost 
back to the starting level.  
 The percentage reduction of the increase in blood 
glucose level caused by the different fractions at first hour 
after glucose load was calculated as below. 
Percentage reduction 
of the increase in blood 
glucose level with 
respect to control  
= 
(BGL c1 - BGL c0) - (BGL t - BGL 
t0) x 100% 
(BGL c1 - BGL c0) 
BGL c0 – Blood glucose level of control 1st hour after 
administration of water immediately before the glucose 
load. 
BGL c1 – Blood glucose level of control 1 hour after 
administration of glucose load. 
BGL t0 - Blood glucose level of test group 1st hour after 
administration of sample immediately before the glucose 
load. 
BGL t1 – Blood glucose level of test group 1 hour after 
administration of glucose  
It should be noted that our method of calculating the effect 
of the test substances in lowering blood glucose is more 
accurate than the commonly used method of calculating it 
using the equation  
Percentage reduction in 
blood glucose level      = 
(BGL c - BGL t ) x 100% 
BGL c 
 As it compensates for the difference in the initial 
blood glucose levels between the control group and the 
test substances groups. 
 Calculated percentage reduction of the increase in 
blood glucose level of the fractions of EA/W at 2 hours 
after administration of sample was given in Figure 4 and it 
show that all the fractions except fraction 2 and fraction 1, 
show leased glucose elevation after glucose load. The 
EA/W was the fraction which had lowest glucose reduction 
curve with the time. Fraction 2, 3, 4 and 5 also have 
reduced blood glucose level time curve than the normal 
control rats.  
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Effects on blood glucose levels in diabetic rats with the 
administration of a glucose load (Glucose tolerance 
Test)  
 Of the five fractions obtained from sephadex LH-
20 column fractions 1 and 2 did not show activities. As a 
result only the fractions 3,4,5 and EA/W were subjected to 
the study.  
 The results obtained are given in Figure 5. The 
results clearly show that all fractions (Fraction 3, 4, 5 and 
EA/W) have ability to reduce the post load of glucose than 
the control. As in normal rats, the highest blood glucose 
level was observed at the 1st hour after the glucose load. 
However the rate of reduction in blood glucose level 
thereafter was much slower than in normal rats. Therefore 
the EA/W shows the maximum percentage reduction with 
respect to control. Comparing the three fractions 
maximum percentage reduction of blood glucose is seen in 
fraction 3. Thus, there is no enhancement of activity in the 
fractions.  
 Although the composition of the three fractions 
were different from each other and from EA/W as 
analyzed by thin layer chromatography, there are no 
significant difference (p>0.01) in the activities. This 
suggests that EA/W contains many different compounds 
having approximately the same activity. 
 When comparing all the in vivo results we can 
clearly see that optimum time of action is at the end of the 
2nd hour after administration of sample.  
CONCLUSION  
 The ethyl acetate fraction of the water extract of 
the senescent leaves of A. heterophyllus was fractionated 
into five fractions using Sephadex LH-20. Fractions 3, 4 
and 5 were the most active for in vivo studies. Fraction 4 
showed highest activity in reducing blood glucose levels, 
while fraction 3 was the most active in the glucose 
tolerance test, indicating that fraction 3 contain a glucose 
uptake inhibitor. These results maybe of potential use for 
the development of an anti diabetic drug from leaves of 
Artocarpus heterophyllus. 
FIGURES 
 
Figure 1: Variation of blood glucose levels with time in diabetic rats after administration of fractions of EA/W. 
(Value at t=0 correspond to fasting blood glucose level) 
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Figure 2: Reduction in blood glucose levels with time in diabetic rats after administration of fractions of EA/W. 
 
Figure 3: Variation of blood glucose levels of normoglyceamic rats with the time after administration of sample 
followed by glucose load. 
Value at t=0 correspond to fasting blood sugar level 
 
Figure 4: Percentage reduction of blood glucose level of normoglyceamic rats with glucose load with respect to 
control one hour after glucose load 
 
Figure 5: Variation of blood glucose levels of diabetic rats with time after administration of sample followed by 
glucose load 
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Figure 3.8: Percentage reduction of increase in blood glucose level of diabetic rats with glucose load with respect 
to control one hour after glucose load 
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